|
Calyx Bio-Ventures (formerly Chromos Molecular Systems) wants you to part with that chromosome. The company is developing therapeutic products to fight diseases based on its REM (rapid expansion method) technology. The company has sold its ACE System (artificial chromosome expression) technology but retains some rights to use the ACE System for gene therapy applications. The system's potential biopharmaceutical product applications include therapies for infectious diseases and cancers. The company emerged from bankruptcy protection in late 2007 and completed its restructuring when it merged its operations into its Calyx subsidiary the following year.
|
| | | Contact Information | |
Address: |
8081 Lougheed Hwy.
Burnaby, British Columbia V5A 1W9, Canada
| | Phone: | 604-415-7100 | | Fax: | 604-415-7151 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2007): | 2.00 M | | Revenue Growth (1 yr): | 53.90% | | Employees (2007): | 5 | | Employee Growth (1 yr): | (-81.50%) |
|
|
Key People
| | • |
Chairman and CEO:
Darrell J. Elliott
| | • |
VP Finance and CFO:
Jeff Charpentier
|
|
|
